Arcus Biosciences (RCUS)
(Real Time Quote from BATS)
$18.13 USD
+0.74 (4.26%)
Updated Sep 13, 2024 02:40 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 41 - 60 ( 127 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Fourth Interim Analysis of ARC-7 Indicates Promising PFS; Clinical Data in Dec
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; ARC-10 Study Amended; ARC-7 Update Ahead
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- EORTC-NCI-AACR 2022: Covered Companies Roundup
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ARC-7 Data Ahead; Broad TIGIT Plan Continues Expansion
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AB521 Demonstrates Promising Profile; Clinical Program on Track
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R